KL590586
Ellipses
['solid tumor']
abstracts on #ret inhibitors from the asco annual meeting in 2023:
1abstract 9065: first results from the retgistry: a global consortium for the study of resistance to ret inhibition in ret-altered solid tumors.
2abstract 3007: a phase i study of kl590586, a next-generation 
Chief, Early-Phase Drug Development|@SarahCannonDocs
#Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.